Hamburg, May 19, 2022 – From May 12 to 15, 2022, Beiersdorf hosted the who’s who of international Q10 research at the tenth conference of the International Coenzyme Q10 Association (ICQA) held at its research center in Hamburg. Approximately 160 attendees discussed the latest findings regarding the coenzyme produced naturally by the body as well as its vital importance. “Following the last ICQA event in New York in 2018, it was a huge honor for us to be able to welcome researchers from all over the world to our site in Hamburg,” emphasizes Dr. Gitta Neufang, Corporate Senior Vice President, Research and Development. “Beiersdorf scientists have been intensively researching the essential coenzyme Q10 since the early 1990s. In 1998, we succeeded in making Q10 available in antiaging skin care products for the first time. We are as proud of this pioneering work as we are of our other contributions to research. We are therefore all the more delighted that this has been recognized by the members of the ICQA.”
The International Coenzyme Q10 Association was founded by renowned scientists from around the world in September 1997 and is based at the Institute of Biochemistry at the Marche Polytechnic University in Ancona, Italy. The purpose of the research association is to regularly share the latest findings regarding Q10 across a large number of scientific disciplines including research into Parkinson’s, diabetes, and cancer. With their focus on skin, Beiersdorf scientists have been part of the close circle of experts since the beginning, have published their research findings in renowned journals, and communicate their expertise at numerous specialist events. Represented by Dr. Julia Weise, Lab Manager, Biological Testing, Beiersdorf gave insights into its research work for the eighth time at this year’s ICQA conference, thereby emphasizing its leading role in Q10 skin research. “Q10 still offers considerable potential in the area of antiaging skin care as we continue to discover new details. In the more than 20 years of our intensive research work, we have continuously expanded our knowledge and also collaborate with renowned external partners,” explains Dr. Julia Weise.
The latest study was produced together with Beiersdorf’s long-standing cooperation partner Luca Tiano, professor at the university in Ancona and ICQA board member. In their joint work, the scientists proved that the decline in Q10 in skin cells due to age is a cause of skin aging and also weakens connective tissue structures. “This knowledge gives us an even better understanding of the key function of Q10 and allows us to specifically influence skin cell vitality,” reports Dr. Julia Weise. “We also proved on a skin model that you can replenish a Q10 deficit and that cells can therefore be biologically rejuvenated.”
Successes like these allow Beiersdorf to continuously expand its Q10 formula platform and steadily improve the efficacy of Q10 products, for example by being combined with highly effective active ingredients such as creatine and vitamin C. This makes Q10 research a prime example of how initial pioneering work by the Hamburg-based company benefits from the latest research findings. The success story of modern-day active ingredient cosmetics and antiaging skin care began in 1998 with the introduction of the first NIVEA Q10 skin care product to the mass market. It continues to bear fruit to this day with numerous innovations.
